
ESC TV Today – Your Cardiovascular News
The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter.
You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!
Latest episodes

Oct 26, 2023 • 21min
Season 2 - Ep. 3: Arrhythmogenic mitral valve prolapse - Peripartum cardiomyopathy
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Peripartum cardiomyopathy Arrhythmogenic mitral valve prolapse Statistics Made Easy: The ‘Win Ratio’ Host: Perry Elliott Guests: Carlos Aguiar, Johann Bauersachs and Kristina Haugaa Want to watch that episode? Go to: https://esc365.escardio.org/event/1138 Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Kristina Haugaa and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Johann Bauersachs has declared to have potential conflicts of interest to report: direct personal payment from healthcare industry: speaker fees, honoraria, consultancy, advisory board fees, investigator, committee member, etc. by Roche Diagnostics (Acute Heart Failure), Pfizer (Atrial Fibrillation), Bristol Myers Squibb (Atrial Fibrillation), Bayer (Chronic Heart Failure), Boehringer-Ingelheim (Chronic Heart Failure), Novartis (Chronic Heart Failure), CVRx (Chronic Heart Failure), AstraZeneca (Chronic Heart Failure), Cardior (Chronic Heart Failure), Norgine (Chronic Heart Failure). Research funding from healthcare industry under your direct/personal responsibility (to department or institution): Roche Diagnostics (Atrial fibrillation, co-investigator), Norgine (heart failure / iron deficiency, principal investigator), Zoll Medical (heart failure, co-investigator), CVRx (heart failure, investigator). Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Oct 12, 2023 • 19min
Season 2 - Ep. 2: LV non-compaction / Excessive LV trabeculation - GLP1-receptor agonists: the next revolution in heart disease?
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies GLP1-Receptor Agonists - the next revolution in heart disease? Left-ventricular non-compaction or excessive left-ventricular trabeculation Snapshots Host: Susanna Price Guests: Stephan Achenbach, Carlos Aguiar, Ulrich Laufs and Steffen Petersen. Want to watch that episode? Go to: https://esc365.escardio.org/event/1137 Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Ulrich Laufs and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy to Circle Cardiovascular Imaging. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Sep 28, 2023 • 22min
Season 2 - Ep. 1: Key messages of the 2023 ESC Guidelines on ACS - "Long COVID" and the heart
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Key messages of the new ESC Guidelines on the Management of Acute Coronary Syndromes "Long COVID" and the heart Mythbusters: Is it true that “Weekend Warriors” experience no health benefits? Host: Susanna Price Guests: Carlos Aguiar, Robert Byrne and Eric Topol. Want to watch that episode? Go to: https://esc365.escardio.org/event/1136 Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Eric Topol have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Robert Byrne has declared to have potential conflicts of interest to report: research funding from healthcare industry under your direct/personal responsibility (to department or institution) for Biosensors (clinical trial activity, principal investigator), Boston Scientific (research/educational grant to institution of employment to support fellowship programme, clinical director), Abbott Vascular (research/educational grant to institution of employment to support fellowship programme, clinical director), Translumina :(research/educational grant to institution of employment to support research nurse for patient outcomes, clinical director). Membership or affiliation in political or advocacy groups working in the field of cardiology: ESC representative at Biomedical Alliance Member of Irish Heart Attack Audit Governance Committee Member Health Products, Regulatory Authority (HPRA; Irish Competent Authority) Advisory Committee on Medical Devices, Deputy Editor at EuroIntervention Guest Editor at Circulation. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Aug 10, 2023 • 21min
Episode 22: Among the topics: Magnetic Resonance Imaging, pacemakers and ICDs - Tough problems in the treatment of hypertension
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Magnetic Resonance Imaging, pacemakers and ICDs Tough problems in the treatment of hypertension Snapshots Host: Rick Grobbee Guests: Stephan Achenbach, Chiara Bucciarelli-Ducci, Christophe Leclerq, Bryan Williams. Want to watch that episode? Go to: https://esc365.escardio.org/event/1123 Disclaimer This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Chiara Bucciarelli-Ducci has declared to have potential conflicts of interest to report: CEO (part time) of the Society for Cardiovascular Magnetic Resonance. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Christophe Leclerq has declared to have potential conflicts of interest to report: lectures and consultancies for Abbott, Biotronik, and Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme. Bryan Williams has declared to have potential conflicts of interest to report: chair of steering committees for trails for Novartis and AstraZeneca.

Jul 27, 2023 • 22min
Episode 21: Among the topics: Edge-to-edge mitral valve repair - The future treatment of chronic heart failure
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Edge-to-edge mitral valve repair The future treatment of chronic heart failure Mythbusters: Is chocolate healthy for the heart? Host: Susanna Price Guests: Carlos Aguiar, Milton Packer and Stephan Windecker Want to watch that episode? Go to: https://esc365.escardio.org/event/1122 Disclaimer This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Milton Packer and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme. Stephan Windecker has declared to have potential conflicts of interest to report: payments from Amgen and Medtronic, research funding from Abbott, Amgen, AstraZeneca, Bayer AG, Biotronik, Boston Scientific, Daiichi Sankyo, Edwards Lifesciences, Guerbet AG, Johnson & Johnson, Medtronic, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi Adventis, V-Wave, Abiomed, Boehringer-Ingelheim, Bristol Myers Squibb, B.Braun, Cordis Medical, Miracor medical, Pharming Tech, CSL Behring, Farapulse Inc., Fumedica, Idorsia, Inari Medical, MedAlliance.

Jul 13, 2023 • 21min
Episode 20: Among the topics: Healthy nutrition in a nutshell - Indications for catheter ablation of atrial fibrillation
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Healthy nutrition in a nutshell Indications for catheter ablation of atrial fibrillation Snapshots Host: Susanna Price Guests: Isabel Deisenhofer and Dariush Mozaffarian Want to watch that episode? Go to: https://esc365.escardio.org/event/1096 Disclaimer This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Isabel Deisenhofer, Nicolle Kraenkel, Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Dariush Mozaffarian has declared to have potential conflicts of interest to report: research funding from the National Institutes of Health, the Gates Foundation, The Rockefeller Foundation, Vail Innovative Global Research, and the Kaiser Permanente Fund; personal fees from Acasti Pharma and Barilla; scientific advisory board, Beren Therapeutics, Brightseed, Calibrate, Elysium Health, Filtricine, HumanCo, Instacart Health, January Inc., and Perfect Day (ended: Day Two, Season Health, and Tiny Organics); stock ownership in Calibrate and HumanCo; and chapter royalties from UpToDate. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Jun 29, 2023 • 19min
Episode 19: Among the topics: Microvascular angina - Minimally invasive tricuspid valve surgery
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Microvascular angina Minimally invasive tricuspid valve surgery Mythbusters: An apple a day keeps the doctor away Host: Rick Grobbee Guests: Volkmar Falk and Eva Prescott Want to watch that episode? Go to: https://esc365.escardio.org/event/1095 Disclaimer This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Eva Prescott have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Volkmar Falk has declared to have potential conflicts of interest to report: Medtronic GmbH, Biotronik SE & Co., Abbott GmbH & Co. KG, Boston Scientific, Edwards Lifesciences, LivaNova, Berlin Heart, Novartis Pharma GmbH, JOTEC GmbH, Zurich Heart. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Jun 15, 2023 • 21min
Episode 18: Among the topics: Management of left ventricular thrombus - Diagnosis and treatment of HFpEF
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Management of left ventricular thrombus Diagnosis and treatment of HFpEF – State of the art in 2023 Diagnostics Made Easy: Constriction vs. restriction in echocardiography Host: Rick Grobbee Guests: Glenn Levine and Theresa McDonagh Want to watch that episode? Go to: https://esc365.escardio.org/event/1083 Disclaimer This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel, Glenn Levine and Theresa McDonagh have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Jun 1, 2023 • 20min
Episode 17: Among the topics: Takotsubo Syndrome - Arrhythmogenic Right Ventricular Cardiomyopathy
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Takotsubo Syndrome Arrhythmogenic Right Ventricular Cardiomyopathy Mythbusters – Red rice - an alternative to statins? Host: Rick Grobbee Guests: Kristina Haugaa and Thomas Luescher Want to watch that episode? Go to: https://esc365.escardio.org/event/1077 Disclaimer This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Thomas Luescher have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

May 18, 2023 • 23min
Episode 16: Among the topics: Sleep and heart health - Device-detected atrial fibrillation
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Sleep and heart health Device-detected atrial fibrillation Statistics Made Easy: Regression to the mean Host: Carlos Aguiar Guests: Donald Llyold-Jones, Isabelle van Gelder and Katya Reis Santos. Want to watch that episode? Go to: https://esc365.escardio.org/event/1038 Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Donald Llyold-Jones, Isabelle van Gelder and Katya Reis Santos have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.